Other highlights in the October 15 issue of JNCI

December 31, 2000

Study Confirms Risk Factors for Malignant Melanoma

A new study confirms previous findings that hair color, number of moles on the legs, and history of sunburn are risk factors for malignant melanoma. The study also found that the use of sunbeds and other tanning devices is associated with an increased risk of the disease. Marit Veierød, Ph.D., of the University of Oslo in Norway, and colleagues surveyed 106,379 Norwegian and Swedish women between the ages of 30 and 50 about their personal characteristics and exposures. During an average follow-up of 8.1 years, there were 187 cases of melanoma diagnosed among these women. Melanoma risk was associated with increasing body surface area; the number of large asymmetric moles on the legs; having naturally red hair; the number of sunburns per year during the second, third, and fourth decades of life; and use one or more times per month of artificial tanning lights. The authors also note that the strongest effects of UV exposure on melanoma risk appear to be during adolescence and early adulthood.

Low White Cell Counts May Affect Breast Cancer Outcomes Among African American Women

African American women with early-stage breast cancer have lower baseline white blood cell counts and therefore appear to have delays in doses of adjuvant chemotherapy compared with white women with early-stage breast cancer. The treatment delays may explain racial differences in breast cancer survival, authors of a new study suggest. Dawn Hershman, M.D., of the New York-Presbyterian Hospital in New York, and her colleagues collected information on 73 African American and 126 matched white women, and of these women, 43 white and 93 African American women had undergone adjuvant chemotherapy. They found that African American women had lower white blood cell counts at baseline and after treatment and required a longer treatment duration (19 weeks versus 15 weeks). "This difference in dose intensity may contribute to the observed disparities in survival between African American women and white women with breast cancer," the researchers write.

Contact: Alicia Park, New York-Presbyterian Hospital, 212-305-5587, alk9007@nyp.org.

SV40 Does Not Appear to Be a Prevalent Human Pathogen, Study Concludes

There is a lack of evidence that simian virus 40 (SV40) is a prevalent human pathogen, a new study concludes. Poliovirus vaccines used between 1955 and 1963 were inadvertently contaminated with SV40. Because SV40 DNA has been detected in tumors from individuals who are too young to have been exposed to SV40 contaminated vaccines, there is a concern that SV40 has become a prevalent human pathogen as a result of human-to-human transmission. Joseph J. Carter and Denise A. Galloway, Ph.D., of the Fred Hutchinson Cancer Research Center in Seattle, and colleagues examined the prevalence of SV40 and two related polyomaviruses, JCV and BKV, in serum samples from 212 patients with osteosarcoma or prostate cancer and 487 healthy control subjects. They found that BKV and JCV antibodies were prevalent in all serum samples examined, but only 6.6% of samples had SV40 antibodies, none of which could be confirmed as having authentic SV40 antibodies, but rather appeared to be due to non-specific cross-reaction to one of the other two viruses. The authors conclude that the data do not support the theory that SV40 is a prevalent human pathogen.

Contact: Kristen Woodward, Fred Hutchinson Cancer Research Center, 206-667-5059, kwoodwar@fhcrc.org.

No Increase in Incidence of Childhood Leukemias in Nordic Countries, Study Finds The incidence of childhood leukemias in Nordic countries has been stable for 20 years, according to a new study. Previous studies from various countries had reported an increasing incidence of childhood leukemias in recent decades. Lisa Lyngsie Hjalgrim, M.D., of the Statens Serum Institut in Denmark, and her colleagues examined a database of approximately 5 million children aged 0-14 years in Sweden, Denmark, Norway, Finland, and Iceland for trends in the incidence of childhood acute leukemia over the last 20 years. They found that the incidence rates of acute myeloid leukemia overall, acute lymphoblastic leukemia overall, and specific acute lymphoblastic leukemia immunophenotypes were remarkably stable in these countries during the past two decades.

Titles of additional articles appearing in the October 15 JNCI:
-end-
Note: The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage.

Journal of the National Cancer Institute

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.